Cabante, Theon Ray .

HRN: 22-46-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2023
CEFTRIAXONE 1G (VIAL)
06/21/2023
06/28/2023
IV
600mg
Q24h
Pcap C
Waiting Final Action 
06/26/2023
MUPIROCIN 2%, 15G (TUBE)
06/26/2023
07/03/2023
TOPICAL
Apply Thinly
Q12
IV Site Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: